361 related articles for article (PubMed ID: 8968060)
1. Promoting effects of dimethylarsinic acid on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in rats.
Wanibuchi H; Yamamoto S; Chen H; Yoshida K; Endo G; Hori T; Fukushima S
Carcinogenesis; 1996 Nov; 17(11):2435-9. PubMed ID: 8968060
[TBL] [Abstract][Full Text] [Related]
2. Carcinogenicity of dimethylarsinic acid in male F344 rats and genetic alterations in induced urinary bladder tumors.
Wei M; Wanibuchi H; Morimura K; Iwai S; Yoshida K; Endo G; Nakae D; Fukushima S
Carcinogenesis; 2002 Aug; 23(8):1387-97. PubMed ID: 12151359
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity in (LewisxF344)F1 rat urinary bladder tumors induced with N-butyl-N-(4-hydroxybutyl)nitrosamine followed by dimethylarsinic acid or sodium L-ascorbate.
Chen T; Na Y; Wanibuchi H; Yamamoto S; Lee CC; Fukushima S
Jpn J Cancer Res; 1999 Aug; 90(8):818-23. PubMed ID: 10543252
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of 1,3-diaminopropane, an ornithine decarboxylase inhibitor, on rat two-stage urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Salim EI; Wanibuchi H; Morimura K; Kim S; Yano Y; Yamamoto S; Fukushima S
Carcinogenesis; 2000 Feb; 21(2):195-203. PubMed ID: 10657958
[TBL] [Abstract][Full Text] [Related]
5. Severity of promotion by sodium salts of succinic acid in rat urinary bladder carcinogenesis correlates with sodium ion concentration under conditions of equal urinary pH.
Otoshi T; Iwata H; Yamamoto S; Murai T; Yamaguchi S; Matsui-Yuasa I; Otani S; Fukushima S
Carcinogenesis; 1993 Nov; 14(11):2277-81. PubMed ID: 8242855
[TBL] [Abstract][Full Text] [Related]
6. Summation effects of uracil and other promoters on epithelial lesion development in the F344 rat urinary bladder initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
de Camargo JL; Shirai T; Kato T; Asamoto M; Fukushima S
Jpn J Cancer Res; 1991 Nov; 82(11):1220-5. PubMed ID: 1752781
[TBL] [Abstract][Full Text] [Related]
7. Promotion by sodium L-ascorbate in rat two-stage urinary bladder carcinogenesis is dependent on the interval of administration.
Chen TX; Wanibuchi H; Murai T; Kitano M; Yamamoto S; Fukushima S
Jpn J Cancer Res; 1999 Jan; 90(1):16-22. PubMed ID: 10076560
[TBL] [Abstract][Full Text] [Related]
8. Cancer induction by an organic arsenic compound, dimethylarsinic acid (cacodylic acid), in F344/DuCrj rats after pretreatment with five carcinogens.
Yamamoto S; Konishi Y; Matsuda T; Murai T; Shibata MA; Matsui-Yuasa I; Otani S; Kuroda K; Endo G; Fukushima S
Cancer Res; 1995 Mar; 55(6):1271-6. PubMed ID: 7882321
[TBL] [Abstract][Full Text] [Related]
9. Promotion of NCI-Black-Reiter male rat bladder carcinogenesis by dimethylarsinic acid an organic arsenic compound.
Li W; Wanibuchi H; Salim EI; Yamamoto S; Yoshida K; Endo G; Fukushima S
Cancer Lett; 1998 Dec; 134(1):29-36. PubMed ID: 10381127
[TBL] [Abstract][Full Text] [Related]
10. Ethanol-extracted propolis enhances BBN-initiated urinary bladder carcinogenesis via non-mutagenic mechanisms in rats.
Xie XL; Gi M; Fujioka M; Doi K; Yamano S; Tachibana H; Fang H; Kakehashi A; Wanibuchi H
Food Chem Toxicol; 2015 Sep; 83():193-200. PubMed ID: 26111810
[TBL] [Abstract][Full Text] [Related]
11. High susceptibility of p53(+/-) knockout mice in N-butyl-N-(4-hydroxybutyl)nitrosamine urinary bladder carcinogenesis and lack of frequent mutation in residual allele.
Ozaki K; Sukata T; Yamamoto S; Uwagawa S; Seki T; Kawasaki H; Yoshitake A; Wanibuchi H; Koide A; Mori Y; Fukushima S
Cancer Res; 1998 Sep; 58(17):3806-11. PubMed ID: 9731488
[TBL] [Abstract][Full Text] [Related]
12. Urothelial cytotoxicity and regeneration induced by dimethylarsinic acid in rats.
Cohen SM; Yamamoto S; Cano M; Arnold LL
Toxicol Sci; 2001 Jan; 59(1):68-74. PubMed ID: 11134545
[TBL] [Abstract][Full Text] [Related]
13. Dose-dependent amplification by L-ascorbic acid of NaHCO3 promotion of rat urinary bladder carcinogenesis.
Iwata H; Yamamoto S; Yano Y; Ohtani S; Fukushima S
Toxicol Pathol; 1997; 25(3):284-90. PubMed ID: 9210260
[TBL] [Abstract][Full Text] [Related]
14. Diindolylmethane and Lupeol Modulates Apoptosis and Cell Proliferation in N-Butyl-N-(4-Hydroxybutyl) Nitrosamine Initiated and Dimethylarsinic Acid Promoted rat Bladder Carcinogenesis.
Prabhu B; Sivakumar A; Sundaresan S
Pathol Oncol Res; 2016 Oct; 22(4):747-54. PubMed ID: 27091758
[TBL] [Abstract][Full Text] [Related]
15. Concentration dependent promoting effects of sodium L-ascorbate with the same total dose in a rat two-stage urinary bladder carcinogenesis.
Chen TX; Wanibuchi H; Wei M; Morimura K; Yamamoto S; Hayashi S; Fukushima S
Cancer Lett; 1999 Nov; 146(1):67-71. PubMed ID: 10656611
[TBL] [Abstract][Full Text] [Related]
16. Promoting effects of various agents in rat urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Kurata Y; Asamoto M; Hagiwara A; Masui T; Fukushima S
Cancer Lett; 1986 Aug; 32(2):125-35. PubMed ID: 3756839
[TBL] [Abstract][Full Text] [Related]
17. Rosiglitazone, a PPAR gamma agonist: potent promoter of hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers.
Lubet RA; Fischer SM; Steele VE; Juliana MM; Desmond R; Grubbs CJ
Int J Cancer; 2008 Nov; 123(10):2254-9. PubMed ID: 18712722
[TBL] [Abstract][Full Text] [Related]
18. Promoting effect of unilateral nephrectomy on urinary bladder carcinogenesis in rats.
Saikawa S; Kanamaru H; Li B; Matsukawa S; Okada K
Jpn J Cancer Res; 1996 Nov; 87(11):1121-4. PubMed ID: 9045940
[TBL] [Abstract][Full Text] [Related]
19. Patterns of epithelial proliferation revealed by continuous administration of bromodeoxyuridine during urinary bladder carcinogenesis in rats.
Tatematsu M; Fukushima S; Aoki T; Mera Y; Inoue T; Ito N
Jpn J Cancer Res; 1987 Sep; 78(9):879-82. PubMed ID: 3117745
[TBL] [Abstract][Full Text] [Related]
20. Promotion effects of acetoaceto-o-toluidide on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced bladder carcinogenesis in rats.
Yukimatsu N; Gi M; Okuno T; Fujioka M; Suzuki S; Kakehashi A; Yanagiba Y; Suda M; Koda S; Nakatani T; Wanibuchi H
Arch Toxicol; 2019 Dec; 93(12):3617-3631. PubMed ID: 31673724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
